Thus, the binding of PDL1-scFv-Fc-RE7 has the ability to cause MHC-I presentation of E7 antigen by tumor cell, rendering the tumor cell susceptible to E7-specific CD8+ T cell-mediated killing. Here, CD8A is linked to neoplasm.